Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: M and A...

I agree - PTSC should move very carefully re a merger and or acquisition.

The potential M&A hazards are many including significant share dilution, PTSC's stockholders getting less of the pie, and a possible miscalsulation that puts us in bed with a company that becomes an anchor on earnings.  

 

Share
New Message
Please login to post a reply